Total submissions: 31
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000120406 | SCV000150070 | benign | not specified | 2017-05-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001084461 | SCV000153857 | benign | Familial cancer of breast; Fanconi anemia complementation group J | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000116161 | SCV000185903 | benign | Hereditary cancer-predisposing syndrome | 2014-08-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV000120406 | SCV000314843 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Counsyl | RCV000410926 | SCV000489805 | benign | Fanconi anemia complementation group J | 2016-05-25 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000412457 | SCV000489806 | benign | Ovarian neoplasm | 2016-05-25 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000120406 | SCV000889220 | benign | not specified | 2021-08-09 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000116161 | SCV000902553 | benign | Hereditary cancer-predisposing syndrome | 2015-10-15 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000990030 | SCV001140794 | likely benign | Familial cancer of breast | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000410926 | SCV001287319 | likely benign | Fanconi anemia complementation group J | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
ARUP Laboratories, |
RCV000759713 | SCV001474040 | benign | not provided | 2022-03-07 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV000759713 | SCV002010893 | likely benign | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001798360 | SCV002043639 | benign | Breast and/or ovarian cancer | 2023-05-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000759713 | SCV002063644 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | BRIP1: BP4, BS2 |
Genetic Services Laboratory, |
RCV000120406 | SCV002066921 | benign | not specified | 2019-02-27 | criteria provided, single submitter | clinical testing | |
National Health Laboratory Service, |
RCV002225334 | SCV002505046 | benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000116161 | SCV002533720 | benign | Hereditary cancer-predisposing syndrome | 2020-10-09 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000120406 | SCV002551207 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001084461 | SCV002801283 | likely benign | Familial cancer of breast; Fanconi anemia complementation group J | 2021-08-23 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000990030 | SCV004016915 | benign | Familial cancer of breast | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000990030 | SCV004019479 | benign | Familial cancer of breast | 2023-03-02 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. Homozygosity for this variant has been confirmed in one or more individuals lacking clinical features consistent with gene-specific recessive disease, indicating that this variant is unlikely to be pathogenic. |
Breakthrough Genomics, |
RCV000759713 | SCV005211185 | likely benign | not provided | criteria provided, single submitter | not provided | ||
ITMI | RCV000120406 | SCV000084558 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
True Health Diagnostics | RCV000116161 | SCV000805254 | likely benign | Hereditary cancer-predisposing syndrome | 2018-05-30 | no assertion criteria provided | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001358435 | SCV001554165 | benign | Malignant tumor of breast | no assertion criteria provided | clinical testing | The BRIP1 p.Val193Ile variant was identified in 4 of 726 proband chromosomes (frequency: 0.006) from individuals with breast and prostate cancer and was present in 14 of 4556 control chromosomes (frequency: 0.003) from healthy individuals (Kote-Jarai 2009,Rutter 2003, Vahteristo 2006, Wong 2011). The variant was identified in dbSNP (rs4988346) as “with benign allele”, ClinVar (interpreted as "benign" by Invitae and 8 others and "likely benign" by True Health Diagnostics). The variant was identified in control databases in 986 of 277,084 chromosomes (9 homozygous) at a frequency of 0.004 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 13 of 24,026 chromosomes (freq: 0.0005), Other in 39 of 6462 chromosomes (freq: 0.006), Latino in 135 of 34,414 chromosomes (freq: 0.004), European in 650 of 126,616 chromosomes (freq: 0.005), Ashkenazi Jewish in 54 of 10,148 chromosomes (freq: 0.005), Finnish in 27 of 25,780 chromosomes (freq: 0.001), and South Asian in 68 of 30,782 chromosomes (freq: 0.002). The variant was not observed in the East Asian population. The p.Val193 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. | |
Diagnostic Laboratory, |
RCV000759713 | SCV001742962 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000759713 | SCV001808455 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics Laboratory, |
RCV000120406 | SCV001906447 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000759713 | SCV001931320 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000759713 | SCV001955968 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000120406 | SCV002036294 | benign | not specified | no assertion criteria provided | clinical testing |